Taiwan Biomaterial Company Description

Taiwan Biomaterial Co., Ltd. engages in the development and sale of implantable medical devices in Taiwan.

It offers Foamagen, a foamagen dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery; tissue repair and regeneration products for the treatment of early osteoarthritis; and CDMO.

The company was founded in 1921 and is based in Zhubei, Taiwan.